Table 2.
|
Responders to GFD after | |||||
2 months | 6 months | 12 months | ||||
No | Yes | No | Yes | No | Yes | |
N (%) | 56 (43) | 74 (57) | 25 (30) | 59 (70) | 21 (24) | 67 (76) |
Gender* | ||||||
Female, n (%) | 40 (40) | 60 (60) | 18 (28) | 47 (72) | 19 (27) | 52 (73) |
Male, n (%) | 16 (53) | 14 (47) | 7 (37%) | 12 (63) | 2 (12) | 15 (88) |
IBS type* | ||||||
IBS-M, n (%) | 33 (49) | 34 (51) | 18 (38) | 29 (62) | 15 (33) | 31 (67) |
IBS-D, n (%) | 16 (32) | 34 (68) | 6 (19) | 26 (81) | 5 (15) | 29 (85) |
IBS-C, n (%) | 7 (54) | 6 (46) | 1 (20) | 4 (80) | 1 (13) | 7 (87) |
HLA-DQ2 or -DQ8 expression* | ||||||
DQ2/DQ8 negative, n (%) | 36 (54) | 31 (46) | 16 (35) | 30 (65) | 14 (32) | 30 (68) |
DQ2/DQ8 positive, n (%) | 20 (37) | 34 (63) | 9 (27) | 24 (73) | 7 (19) | 30 (81) |
*No significant differences in the proportion of responders.
GFD, gluten-free diet; IBS, irritable bowel syndrome.